Search results
CCEP vs. KO: Which Stock Is the Better Value Option?
Zacks via Yahoo Singapore Finance· 1 day agostock's expected earnings growth rate. KO currently has a PEG ratio of 3.54. Another notable valuation metric for CCEP is its P/B ratio of 3.82. The P/B...
BRFS or CELH: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Singapore Finance· 1 day agoCELH currently has a PEG ratio of 1.61. Another notable valuation metric for BRFS is its P/B ratio...
GMED vs. SONVY: Which Stock Is the Better Value Option?
Zacks via Yahoo Singapore Finance· 1 day agoSONVY currently has a PEG ratio of 2.93. Another notable valuation metric for GMED is its P/B ratio...
ISNPY or TD: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Singapore Finance· 1 day agoTD currently has a PEG ratio of 1.54. Another notable valuation metric for ISNPY is its P/B ratio of...
YETI or POOL: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Singapore Finance· 1 day agoPOOL currently has a PEG ratio of 2.15. Another notable valuation metric for YETI is its P/B ratio...
FUTU vs. TRI: Which Stock Should Value Investors Buy Now?
Zacks via Yahoo Singapore Finance· 1 day agoTRI currently has a PEG ratio of 6.38. Another notable valuation metric for FUTU is its P/B ratio of...
CRAI or IT: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Singapore Finance· 1 day agoIT currently has a PEG ratio of 3.92. Another notable valuation metric for CRAI is its P/B ratio of...
PGRE vs. OHI: Which Stock Is the Better Value Option?
Zacks via Yahoo Singapore Finance· 1 day agoOHI currently has a PEG ratio of 1.17. Another notable valuation metric for PGRE is its P/B ratio of...
HII vs. LMT: Which Stock Is the Better Value Option?
Zacks via Yahoo Singapore Finance· 1 day agoLMT currently has a PEG ratio of 4.32. Another notable valuation metric for HII is its P/B ratio of 2.31. The P/B ratio is used to compare a stock's...
FDA Approves Expanded Use Of Arcutis Biotherapeutics' Eczema Drug For Patients As Young As 6 Years
Benzinga via Yahoo Singapore Finance· 1 day agoOn Tuesday, the FDA approved Arcutis Biotherapeutics Inc’s (NASDAQ:ARQT) supplemental new drug...